The current situation with COVID-19 is of serious concern for the ERS.
In the short term, ERS is working with its membership to ensure that it can contribute and lead in the information and knowledge sharing around the virus and its spread, and the treatment of patients who have COVID-19.
ERS is continuously assessing the risks associated with its activities and will act accordingly to ensure that these risks are minimised for its membership, respiratory patients, sponsors, people affected by the virus and the general public.
Decisions around the ERS International Congress, which is due to be held in September, will be made at the appropriate time and all options are currently being investigated. ERS will keep you regularly updated and release a further statement in April or earlier if necessary.